Variant report
Variant | esv3332695 |
---|---|
Chromosome Location | chr5:93495396-93497444 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs146614696 | chr5:93495404-93495405 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs140280173 | chr5:93495429-93495430 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs531913334 | chr5:93495476-93495477 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs545142926 | chr5:93495506-93495507 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs28637444 | chr5:93495548-93495549 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs575614465 | chr5:93495575-93495576 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs6556841 | chr5:93495631-93495632 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs567583205 | chr5:93495719-93495720 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs529921451 | chr5:93495802-93495803 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs549634480 | chr5:93495876-93495877 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs569530677 | chr5:93495980-93495981 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs533529786 | chr5:93496011-93496012 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs543765657 | chr5:93496022-93496023 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs74661445 | chr5:93496083-93496084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs557831296 | chr5:93496087-93496088 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs529605791 | chr5:93496108-93496109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs113438520 | chr5:93496124-93496125 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs9790957 | chr5:93496157-93496158 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs182764281 | chr5:93496177-93496178 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs144050123 | chr5:93496281-93496282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs553866991 | chr5:93496301-93496302 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs376879596 | chr5:93496315-93496316 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs566054805 | chr5:93496324-93496325 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs146414648 | chr5:93496339-93496340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs542973862 | chr5:93496340-93496341 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs140712081 | chr5:93496366-93496367 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs528617112 | chr5:93496405-93496406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs150156608 | chr5:93496429-93496430 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs6882733 | chr5:93496455-93496456 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs182084826 | chr5:93496529-93496530 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs115518340 | chr5:93496544-93496545 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs541047827 | chr5:93496590-93496591 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs1371285 | chr5:93496811-93496812 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
34 | rs529655563 | chr5:93496843-93496844 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs77097349 | chr5:93496881-93496882 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs569567735 | chr5:93496885-93496886 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs537201668 | chr5:93496899-93496900 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs186189341 | chr5:93496904-93496905 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs551943265 | chr5:93496908-93496909 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs571748164 | chr5:93496941-93496942 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs375608649 | chr5:93496971-93496972 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs556874026 | chr5:93496972-93496973 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs534015048 | chr5:93497010-93497011 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs138639925 | chr5:93497037-93497038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs73773579 | chr5:93497083-93497084 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs536610349 | chr5:93497092-93497093 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs556902078 | chr5:93497124-93497125 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs576808406 | chr5:93497183-93497184 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs190563937 | chr5:93497205-93497206 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs182942696 | chr5:93497221-93497222 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Mental retardation | 19471318 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Williams Syndrome | 20824207 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:93485000-93495400 | Weak transcription | Pancreas | Pancrea |
2 | chr5:93486800-93496800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr5:93489200-93499200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr5:93493200-93495400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
5 | chr5:93493800-93506600 | Weak transcription | H1 Cell Line | embryonic stem cell |
6 | chr5:93494000-93495400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr5:93494400-93495800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr5:93494600-93507000 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
9 | chr5:93495000-93497800 | Weak transcription | Fetal Lung | lung |
10 | chr5:93495200-93506400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
11 | chr5:93495200-93508400 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
12 | chr5:93495400-93495800 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
13 | chr5:93495400-93506200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
14 | chr5:93495800-93496000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
15 | chr5:93496000-93506200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
16 | chr5:93496800-93497000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |